---
figid: PMC7993678__aging-13-202547-g006
figlink: pmc/articles/PMC7993678/figure/f6/
number: F6
caption: Cancer associated fibroblasts (CAFs) from osimertinib-resistant patients
  promoted osimertinib resistance via HGF/MET signaling and induction of epithelial-to-mesenchymal
  transition (EMT) and transformed NSCLC cells into TKI resistant stem-like cells.
  The treatment of capmatinib (MET inhibitor) inhibited CAF-mediated MET/Akt activation
  bypassing EGFR signaling pathway and re-sensitizing NSCLC towards osimertinib.
pmcid: PMC7993678
papertitle: MET inhibitor, capmatinib overcomes osimertinib resistance via suppression
  of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation
  of cancer-associated fibroblasts.
reftext: Kaibin Zhu, et al. Aging (Albany NY). 2021 Mar 15;13(5):6890-6903.
pmc_ranked_result_index: '4388'
pathway_score: 0.7941407
filename: aging-13-202547-g006.jpg
figtitle: Cancer associated fibroblasts (CAFs) from osimertinib-resistant patients
  promoted osimertinib resistance via HGF/MET signaling and induction of epithelial-to-mesenchymal
  transition (EMT) and transformed NSCLC cells into TKI resistant stem-like cells
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7993678__aging-13-202547-g006.html
  '@type': Dataset
  description: Cancer associated fibroblasts (CAFs) from osimertinib-resistant patients
    promoted osimertinib resistance via HGF/MET signaling and induction of epithelial-to-mesenchymal
    transition (EMT) and transformed NSCLC cells into TKI resistant stem-like cells.
    The treatment of capmatinib (MET inhibitor) inhibited CAF-mediated MET/Akt activation
    bypassing EGFR signaling pathway and re-sensitizing NSCLC towards osimertinib.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - CXCL8
  - IL6
  - TGFB1
  - TGFB2
  - TGFB3
  - PDGFB
  - PDGFA
  - PDGFC
  - PDGFD
  - EGFR
  - AKT2
  - AKT3
  - AKT1
  - CTNNB1
  - SNAI1
  - Osimertinib
  - Campatinib
  - NSCLC
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: IL-6/IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6/IL-8
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
chemicals:
- word: Osimertinib
  source: ''
  identifier: ''
- word: Campatinib
  source: ''
  identifier: ''
diseases:
- word: NSCLC
  source: MESH
  identifier: D002289
figid_alias: PMC7993678__F6
redirect_from: /figures/PMC7993678__F6
figtype: Figure
---
